Ardelyx (ARDX) Retained Earnings (2013 - 2026)
Ardelyx (ARDX) posted Retained Earnings of -$984.5 million for Q1 2026, down 3.97% on a QoQ basis from -$946.9 million in Q4 2025, and down 5469788.89% year-over-year from N/an in Q1 2025.
Ardelyx (ARDX) Retained Earnings (2013 - 2026) Analysis & Trends
Ardelyx's Retained Earnings history runs 14 years deep, the most recent figure standing at -$984.5 million for Q1 2026.
- Quarterly Retained Earnings fell 5469788.89% year-over-year to -$984.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$984.5 million (down 5469788.89% YoY) and the FY2025 annual result came in at -$946.9 million, down 6.96% from the prior year.
- Retained Earnings was -$984.5 million for Q1 2026 at Ardelyx, down from -$946.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $185000.0 in Q3 2024 and bottomed at -$984.5 million in Q1 2026.
- A 5-year average of -$456.7 million and a median of -$767.9 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 26361166.67% — and 2024, when it surged 192.04%.
- Ardelyx's Retained Earnings stood at -$780.1 million in 2022, then decreased by 8.47% to -$846.2 million in 2023, then retreated by 4.62% to -$885.3 million in 2024, then declined by 6.96% to -$946.9 million in 2025, then declined by 3.97% to -$984.5 million in 2026.
- Business Quant data shows ARDX's Retained Earnings at -$984.5 million in Q1 2026, -$946.9 million in Q4 2025, and $124000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | -984.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -984.54 Mn |
| Dec 31, 2025 | -946.94 Mn |
| Sep 30, 2025 | 124,000.00 |
| Jun 30, 2025 | -38,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | -885.34 Mn |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | -889.18 Mn |
| Mar 31, 2024 | -872.70 Mn |
| Dec 31, 2023 | -846.20 Mn |
| Sep 30, 2023 | -201,000.00 |
| Jun 30, 2023 | -210,000.00 |
| Mar 31, 2023 | -20,000.00 |
| Dec 31, 2022 | -780.14 Mn |
| Sep 30, 2022 | -790.83 Mn |
| Jun 30, 2022 | -767.94 Mn |
| Mar 31, 2022 | -88,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 4,000.00 |